Literature DB >> 16949463

Pathogenesis of renal anemia.

Masaomi Nangaku1, Kai-Uwe Eckardt.   

Abstract

Anemia is a common complication of chronic kidney disease. Although mechanisms involved in the pathogenesis of renal anemia include chronic inflammation, iron deficiency, and shortened half-life of erythrocytes, the primary cause is deficiency of erythropoietin (EPO). Serum EPO levels in patients with chronic kidney disease are usually within the normal range and thus fail to show an appropriate increase with decreasing hemoglobin levels, as found in nonrenal anemias. Studies elucidating the regulation of EPO expression led to the identification of the hypoxia inducible factor-hypoxia responsive element system. However, despite much progress in understanding the molecular mechanisms through which cells can sense oxygen availability and translate this information into altered gene expression, the reason why EPO production is inappropriately low in diseased kidneys remains incompletely understood. Both alterations in the function of EPO-producing cells and perturbations of the oxygen-sensing mechanism in the kidney may contribute. As with other anemias, the consequences of renal anemia are a moderate decrease in tissue oxygen tensions and counterregulatory mechanisms that maintain total oxygen consumption, including a persistent increase in cardiac output.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16949463     DOI: 10.1016/j.semnephrol.2006.06.001

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  54 in total

1.  Prevalence of kidney disease in anaemia differs by GFR-estimating method: the Third National Health and Nutrition Examination Survey (1988-94).

Authors:  Michelle M Estrella; Brad C Astor; Anna Köttgen; Elizabeth Selvin; Josef Coresh; Rulan S Parekh
Journal:  Nephrol Dial Transplant       Date:  2010-02-22       Impact factor: 5.992

Review 2.  Endocrine functions of the renal interstitium.

Authors:  Armin Kurtz
Journal:  Pflugers Arch       Date:  2017-06-17       Impact factor: 3.657

3.  Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia.

Authors:  Pinelopi P Kapitsinou; Qingdu Liu; Travis L Unger; Jennifer Rha; Olena Davidoff; Brian Keith; Jonathan A Epstein; Sheri L Moores; Connie L Erickson-Miller; Volker H Haase
Journal:  Blood       Date:  2010-07-13       Impact factor: 22.113

4.  Renal Anemia Model Mouse Established by Transgenic Rescue with an Erythropoietin Gene Lacking Kidney-Specific Regulatory Elements.

Authors:  Ikuo Hirano; Norio Suzuki; Shun Yamazaki; Hiroki Sekine; Naoko Minegishi; Ritsuko Shimizu; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2017-02-01       Impact factor: 4.272

5.  Low 1,25-dihydroxyvitamin D level is associated with erythropoietin deficiency and endogenous erythropoietin resistance in patients with chronic kidney disease.

Authors:  Il Young Kim; June Hyun Kim; Min Jeong Kim; Dong Won Lee; Cheol Gu Hwang; Miyeun Han; Harin Rhee; Sang Heon Song; Eun Young Seong; Soo Bong Lee
Journal:  Int Urol Nephrol       Date:  2018-08-22       Impact factor: 2.370

6.  Factors associated with depression and anxiety in patients with end-stage renal disease receiving maintenance hemodialysis.

Authors:  Yue Hou; Xiujiang Li; Lizhi Yang; Chang Liu; Hao Wu; Ying Xu; Fan Yang; Yujun Du
Journal:  Int Urol Nephrol       Date:  2014-03-12       Impact factor: 2.370

7.  First-in-man-proof of concept study with molidustat: a novel selective oral HIF-prolyl hydroxylase inhibitor for the treatment of renal anaemia.

Authors:  M Böttcher; S Lentini; E R Arens; A Kaiser; D van der Mey; U Thuss; D Kubitza; G Wensing
Journal:  Br J Clin Pharmacol       Date:  2018-05-14       Impact factor: 4.335

Review 8.  Therapeutic targeting of the HIF oxygen-sensing pathway: Lessons learned from clinical studies.

Authors:  Volker H Haase
Journal:  Exp Cell Res       Date:  2017-05-05       Impact factor: 3.905

Review 9.  Diabetic nephropathy: a disorder of oxygen metabolism?

Authors:  Toshio Miyata; Charles van Ypersele de Strihou
Journal:  Nat Rev Nephrol       Date:  2009-12-15       Impact factor: 28.314

10.  Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial.

Authors:  Alain Cohen-Solal; Dipak Kotecha; Dirk J van Veldhuisen; Daphne Babalis; Michael Böhm; Andrew J Coats; Michael Roughton; Philip Poole-Wilson; Luigi Tavazzi; Marcus Flather
Journal:  Eur J Heart Fail       Date:  2009-08-01       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.